TET2 and cyclic hematopoiesis: ,2 Loss-of-function heterozygous mutations in TET2 (tet methylcytosine dioxygenase 2) are among the most prevalent and significant drivers of CH and myelodysplastic syndromes, an age-related hematological disease.3